Modular Medical, Inc. financial data

Symbol
MODD on Nasdaq
Location
16772 West Bernardo Drive, San Diego, CA
Fiscal year end
March 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 561 % +25.4%
Debt-to-equity 16.8 % -40.3%
Return On Equity -236 %
Return On Assets -180 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.2M shares +66.7%
Common Stock, Shares, Outstanding 55.3M shares +69.8%
Entity Public Float 62.3M USD +247%
Common Stock, Value, Issued 55K USD +71.9%
Weighted Average Number of Shares Outstanding, Basic 54.3M shares +60.2%
Weighted Average Number of Shares Outstanding, Diluted 54.3M shares +60.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.6M USD +24.8%
General and Administrative Expense 5.01M USD +6.94%
Operating Income (Loss) -21.6M USD -20.2%
Nonoperating Income (Expense) 102K USD +22.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.8M USD +8.83%
Income Tax Expense (Benefit) 2K USD 0%
Net Income (Loss) Attributable to Parent -6.7M USD -62%
Earnings Per Share, Basic 0 USD/shares +25%
Earnings Per Share, Diluted 0 USD/shares +25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.52M USD
Assets, Current 8.29M USD +53.4%
Property, Plant and Equipment, Net 5.21M USD +44%
Operating Lease, Right-of-Use Asset 667K USD -36.2%
Assets 14.2M USD +40.7%
Accounts Payable, Current 1.07K USD -99.8%
Employee-related Liabilities, Current 304K USD
Accrued Liabilities, Current 546K USD +10.3%
Liabilities, Current 2.05M USD +52.8%
Operating Lease, Liability, Noncurrent 278K USD -61.1%
Liabilities 2.33M USD +13.2%
Retained Earnings (Accumulated Deficit) -91.5M USD -30.5%
Stockholders' Equity Attributable to Parent 11.8M USD +47.7%
Liabilities and Equity 14.2M USD +40.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.37M USD -51.4%
Net Cash Provided by (Used in) Financing Activities 733K USD +249%
Net Cash Provided by (Used in) Investing Activities -934K USD -10.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 55.3M shares +69.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.15M USD +33.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.52M USD +48.9%
Deferred Tax Assets, Valuation Allowance 23M USD +19.9%
Deferred Tax Assets, Gross 23.7M USD +22.9%
Operating Lease, Liability 715K USD -35%
Payments to Acquire Property, Plant, and Equipment 934K USD +10.9%
Lessee, Operating Lease, Liability, to be Paid 759K USD -37.5%
Property, Plant and Equipment, Gross 7.31M USD +63.3%
Operating Lease, Liability, Current 437K USD +13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 405K USD -13.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 405K USD -13.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 44K USD -61.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 405K USD -13.9%
Deferred Tax Assets, Operating Loss Carryforwards 14.3M USD +32.1%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 405K USD
Operating Lease, Payments 117K USD +4.46%
Additional Paid in Capital 103M USD +32.3%
Share-based Payment Arrangement, Expense 5K USD -54.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%